The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease

• Published in: Frontiers in immunology Vol. 13; p. 829525
• Main Authors: Thomas, John P, Modos, Dezso, Rushbrook, Simon M, Powell, Nick, Korcsmaros, Tamas
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 03.02.2022
• Subjects: Animals; bile acids; Bile Acids and Salts - metabolism; Bile Acids and Salts - physiology; Crohn’s disease; Dysbiosis - pathology; Gastrointestinal Microbiome - physiology; gut metabolites; Humans; Immunology; immunology and inflammation; inflammatory bowel disease; Inflammatory Bowel Diseases - etiology; Intestinal Mucosa - pathology; ulcerative colitis; immunology and inflammation; gut microbiome; bile acids; ulcerative colitis; inflammatory bowel disease; Crohn’s disease; gut metabolites
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2022.829525

Inflammatory bowel disease (IBD) is a chronic immune-mediated inflammatory disorder of the gastrointestinal tract that arises due to complex interactions between host genetic risk factors, environmental factors, and a dysbiotic gut microbiota. Although metagenomic approaches have attempted to characterise the dysbiosis occurring in IBD, the precise mechanistic pathways interlinking the gut microbiota and the intestinal mucosa are still yet to be unravelled. To deconvolute these complex interactions, a more reductionist approach involving microbial metabolites has been suggested. Bile acids have emerged as a key class of microbiota-associated metabolites that are perturbed in IBD patients. In recent years, metabolomics studies have revealed a consistent defect in bile acid metabolism with an increase in primary bile acids and a reduction in secondary bile acids in IBD patients. This review explores the evolving evidence that specific bile acid metabolites interact with intestinal epithelial and immune cells to contribute to the inflammatory milieu seen in IBD. Furthermore, we summarise evidence linking bile acids with intracellular pathways that are known to be relevant in IBD including autophagy, apoptosis, and the inflammasome pathway. Finally, we discuss how novel experimental and bioinformatics approaches could further advance our understanding of the role of bile acids and inform novel therapeutic strategies in IBD.